NEW YORK CITY, NY / ACCESS Newswire / January 26, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lakeland Industries, Inc. (NASDAQ:LAKE) resulting from allegations that Lakeland may have issued materially misleading business information to the investing public. SO […]

(TSX:ERD),(OTC US:ERDCF),(Other OTC:ERDCF),(OTC US:ERDCD),(Other OTC:ERDCD), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Jan. 26, 2026 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) (“Erdene” or the “Company”) is pleased to announce that it has entered into an agreement with Paradigm

Erdene Announces $25 Million Bought Deal Private Placement GlobeNewswire January 26, 2026 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Jan. 26, 2026 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) (“Erdene” or the “Company”) is pleased to announce that it

Service restored to 214,000+ customers as crews converge on hardest hit areas such as Clayton and Cornelia; Company’s generation fleet prepared to meet demand for electricity during severe cold this week Georgia Power has safely restored power to nearly all customers impacted by Winter Storm Fern. The multiday storm brought high winds, freezing rain, snow,

(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryoncil(R) (remestemcel-L-rknd) since commercially available in March 2025 for the approved label in children 2 months and older with steroid-refractory acute graft-versus-host disease (SR-aGvHD). Ryoncil(R) is

Real-World Commercial Experience with Ryoncil(R) Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment GlobeNewswire January 26, 2026 NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryoncil(R) (remestemcel-L-rknd) since commercially available in

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2026 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ:XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2026 / Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("LENZ" or the "Company") (NASDAQ:LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ:RZLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Rezolute and certain of its officers and/or directors

Bristow Group Inc. (NYSE: VTOL) (the “Company” or “Bristow”) announced today the closing of its private offering of $500 million aggregate principal amount of 6.750% senior secured notes due 2033 (the “notes”) and the amendment and extension of its asset-based revolving credit facility (the “ABL Facility”) until 2031. The notes were issued under an indenture,